Recombinant Human CCL4L1/MIP-1 beta Isoform LAG-1 Protein
Recombinant Human CCL4L1/MIP-1 beta Isoform LAG-1 Protein Summary
Product Specifications
Ala24-Asn92
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
3046-MB
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
Reconstitution | Reconstitute at 100 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
3046-MB/CF
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 100 μg/mL in sterile PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: CCL4L1/LAG-1
CCL4, also known as MIP-1 beta, is a 12 kDa beta chemokine that is secreted by activated leukocytes, lymphocytes, vascular endothelial cells, and pulmonary smooth muscle cells. CCL4 interacts with CCR5 to attract lymphocytes, NK cells, and immature dendritic cells to sites of inflammation (1 - 4). CCL4 also blocks the entry of HIV into CCR5-expressing cells (5). Human CCL4 and its variants are encoded by two paralogous genes(6 - 8), one of which (SCYA4) encodes CCL4 itself (9). The other gene (SCYA4L) is found in two alleles that give rise to CCL4L1 and CCL4L2, respectively (9). The human CCL4L1 cDNA encodes a 92 amino acid (aa) precursor with a 23 aa signal sequence. Alternate splicing yields an isoform with a 40 aa internal deletion. The second allele (SCYA4L2), encoding CCL4L2, is spliced into a variety of isoforms (9). Human CC4L1 shares greater than 98% aa sequence identity with CCL4 and CCL4L2. It shares 96% aa sequence identity with rhesus CCL4 and approximately 80 - 90% aa sequence identity with bovine, mouse, rabbit, and rat CCL4. The gene copy number for CCL4L1 varies from zero to five, but this is not associated with changes in mRNA or protein levels (10). CCL4 and CCL4L1 demonstrate comparable CCR5 binding, promotion of chemotaxis, and inhibition of HIV replication in stimulated PBMC (10, 11). In vivo, the first two N-terminal amino acids of CCL4 are removed by DPPIV. The truncated form is as active as full-length CCL4 and gains the ability to bind CCR1 and CCR2b (12, 13). Similar proteolytic processing of CCL4L1 has not been described.
- Maurer, M. and E. von Stebut (2004) Int. J. Biochem. Cell Biol. 36:1882.
- Menten, P. et al. (2002) Cytokine Growth Factor Rev. 13:455.
- Bisset, L.R. and P. Schmid-Grendelmeier (2005) Curr. Opin. Pulm. Med. 11:35.
- Frangogiannis, N.G. (2004) Inflamm. Res. 53:585.
- Lehner, T. (2002) Trends Immunol. 23:347.
- Modi, W.S. (2004) Genomics 83:735.
- Lu, J. et al. (2004) Immunogenetics 55:706.
- Modi, W.S. (2001) Immunogenetics 53:543.
- Colobran, R. et al. (2005) J. Immunol. 174:5655.
- Townson, J.R. et al. (2002) Eur. J. Immunol. 32:3016.
- Howard, O.M.Z. et al. (2004) Biochem. Biophys. Res. Commun. 320:927.
- Guan, E. et al. (2004) J. Cell. Biochem. 92:53.
- Guan, E. et al. (2002) J. Biol. Chem. 277:32348.
Citation for Recombinant Human CCL4L1/MIP-1 beta Isoform LAG-1 Protein
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
1 Citation: Showing 1 - 1
-
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.
Authors: Wilson TR, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E, Peng J, Lin E, Wang Y, Sosman J, Ribas A, Li J, Moffat J, Sutherlin DP, Koeppen H, Merchant M, Neve R, Settleman J
Nature, 2012-07-26;487(7408):505-9.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human CCL4L1/MIP-1 beta Isoform LAG-1 Protein
There are currently no reviews for this product. Be the first to review Recombinant Human CCL4L1/MIP-1 beta Isoform LAG-1 Protein and earn rewards!
Have you used Recombinant Human CCL4L1/MIP-1 beta Isoform LAG-1 Protein?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image